Alzheimer's Disease News and Research

RSS

Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.

Advances in epilepsy treatment

Epilepsy and seizures affect 2.5 million Americans, 181,000 new cases of epilepsy are diagnosed every year, and the disorder incurs an estimated $12.5 billion in annual direct and indirect costs.

1 Jun 2007

Chocolate good for the memory!

Scientists at the Salk Institute in California say that a chemical found in chocolate improves the memory of mice.

31 May 2007

New hypothesis on Alzheimer's disease

Researchers at Rensselaer Polytechnic Institute are challenging current thinking on the causes and prevention of Alzheimer's disease, offering a new hypothesis that could be the key to preventing this form of dementia.

30 May 2007

Personality test could help doctors detect dementia with Lewy bodies

The study found that even before diagnosis, people with dementia with Lewy bodies displayed passive personality changes, such as diminished emotional response, disinterest in hobbies, repetitive behaviors, and growing apathy, or lack of interest, more often than those with Alzheimer's.

30 May 2007

Inflammation linked to Alzheimer's disease

People whose blood shows signs of inflammation are more likely to later develop Alzheimer's disease than people with no signs of inflammation, according to a study published in the May 29, 2007, issue of Neurology, the scientific journal of the American Academy of Neurology.

30 May 2007

Smart mice miss out on Alzheimer's

Scientists in the U.S. have managed to breed mice which lack the enzyme thought to be the culprit in Alzheimer's disease.

28 May 2007

Research reveals a new mechanism of learning in the brain

Mice genetically engineered to lack a single enzyme in their brains are more adept at learning than their normal cousins, and are quicker to figure out that their environment has changed, a team led by researchers at UT Southwestern Medical Center has found.

28 May 2007

New gene therapy can nearly eliminate arthritis pain

Early-stage research has found that a new gene therapy can nearly eliminate arthritis pain, and significantly reduce long-term damage to the affected joints, according to a study published today in the journal Arthritis and Rheumatism.

28 May 2007

Hormone therapy and menopause study

When is the best time in a woman's reproductive history to start hormone therapy?

24 May 2007

Immune antibodies penetrate neurons to clear Alzheimer's-linked amyloid

Researchers at Weill Cornell Medical College have gotten much closer to understanding how immune-based therapies can treat Alzheimer's disease -- by studying how antibodies go inside brain cells to reduce levels of Alzheimer's-linked amyloid peptides that form plaques between neurons.

24 May 2007

Effects of estrogen therapy with perimenopausal women

When is the best time in a woman's reproductive history to start hormone therapy? How does estrogen therapy affect a woman's cognition and mood? What is the most beneficial form of estrogen?

24 May 2007

New patented method for transporting medicine across the blood-brain barrier

Researchers at the Blanchette Rockefeller Neurosciences Institute have patented a new way of safely transporting medicine across the blood-brain barrier.

24 May 2007

Magnetic resonance elastography enables noninvasive liver diagnoses

Two recent Mayo Clinic studies have found that magnetic resonance elastography (MRE), a new imaging technique invented at Mayo Clinic, is an accurate tool for non-invasive diagnosis of liver diseases.

24 May 2007

New data on the probiotic strain Bifantis

The biotechnology company Alimentary Health has announced results from two studies that demonstrate the anti-inflammatory activity of a natural probiotic bacterial strain of human origin, Bifantis (Bifidobacterium infantis 35624), in models of arthritis and Salmonella infection.

24 May 2007

New understanding of how immune-based therapies can treat Alzheimer's disease

24 May 2007

New data on natural probiotic bacterial strain of Bifantis shows anti-inflammatory properties

The biotechnology company Alimentary Health today announced results from two studies that demonstrate the anti-inflammatory activity of a natural probiotic bacterial strain of human origin, Bifantis (Bifidobacterium infantis 35624), in models of arthritis and Salmonella infection.

22 May 2007